Enanta Pharmaceuticals, Inc. (ENTA) vs X4 Pharmaceuticals, Inc. (XFOR)
- Enanta Pharmaceuticals, Inc. ENTA 11.00 +9.13%
- X4 Pharmaceuticals, Inc. XFOR 3.15 +2.61%
Enanta Pharmaceuticals, Inc. and X4 Pharmaceuticals, Inc. are both Biotechnology companies. Enanta Pharmaceuticals, Inc. and X4 Pharmaceuticals, Inc. are of similar size ($304.4M and $293.6M). Enanta Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 0.70% against −50.1%. Enanta Pharmaceuticals, Inc. has the higher net margin (−96.9% vs −474.7%) and the higher return on invested capital (0.00% vs −178.2%). Across the 17 metrics below, Enanta Pharmaceuticals, Inc. leads on 11 and X4 Pharmaceuticals, Inc. on 6.
Valuation
Profitability
| Metric | ENTA | XFOR | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 81.77% | 68.51% |
| Operating margin | (89.99%) | (473.95%) | 0.00% |
| Net margin | (96.89%) | (474.74%) | 0.00% |
| Free cash flow margin | (56.60%) | (478.16%) | 0.00% |
| Return on equity | (70.12%) | (80.32%) | (51.96%) |
| Return on assets | (21.15%) | (40.73%) | (46.06%) |
| Return on invested capital | 0.00% | (178.23%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack